When was SeqOne founded?

SeqOne was founded in 2017 and raised its 1st funding round 2 years after it was founded.

Where is SeqOne located?

SeqOne is headquartered in Montpellier, France.

How many employees does SeqOne have?

As of Sep 30, 2026, the latest employee count at SeqOne is 118.

Is SeqOne a funded company?

SeqOne is a funded company, having raised a total of $48.8M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Mar 28, 2019.

When was the latest funding round of SeqOne?

SeqOne's latest funding was a $***** Series A round on May 26, 2025, with participation from 4 investors.

Where does SeqOne rank among its competitors?

SeqOne ranks 65th amongst 1568 active competitors, of which 218 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Cellanome, which secured $75.9M in Dec, 2025.

Who are the top competitors of SeqOne?

SeqOne's top competitors include Strand Life Sciences, Benchling and Helix. Among them, Cellanome secured the most recent funding round in December, 2025.

SeqOne - 2026 Company Profile, Team, Funding & Competitors

SeqOne is a series A company based in Montpellier (France), founded in 2017. It operates as a Provider of bioinformatics tools for the analysis of genome sequencing data. SeqOne has raised $48.8M in funding from investors like Elaia, Omnes Capital and Supernova Invest. The company has 1568 active competitors, including 218 funded and 135 that have exited. Its top competitors include companies like Strand Life Sciences, Benchling and Helix.

Company Details

Provider of bioinformatics tools for the analysis of genome sequencing data. The platform helps researchers to detect & identify the variants responsible for gene mutation. It helps to detect many types of variants such as SNPs, Indels, CNVs, and mid-sized deletions.

Website: www.seqone.com/
Social
Email ID: *****@seqone.com
Phone Number: +33 **********

Key Metrics

Founded Year

2017

Location

Montpellier, France

Stage

Series A

Total Funding

$48.8M in 3 rounds

Latest Funding Round

Series A, May 26, 2025, $*****

Investors

Elaia & 8 more

Ranked

65^th among 1568 active competitors

Employee Count

118 as on Sep 30, 2026

Investment & Acquisitions

Congenica

Similar Companies

Benchling & 1161 more

View SeqOne's full profile

SeqOne has raised a total funding of $48.8M over 3 rounds. Its first funding round was on Mar 28, 2019. Its latest funding round was a Series A round on May 26, 2025 for $*****. 4 investors participated in its latest round. SeqOne has 9 institutional investors.

Here is the list of recent funding rounds of SeqOne:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 26, 2025	4269155	Series A	8268737	9903505	2851059	3258514
Jan 24, 2022	5413517	Series A	3903773	7559310	3254947	Software Club & 2 more
Mar 28, 2019	6828772	Series A	9078780	7175310	Elaia	IRDI Soridec Gestion & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of SeqOne's funding rounds and investors

SeqOne's employee count trend

SeqOne has 118 employees as of Sep 26. Here is SeqOne's employee count trend over the years:

Uncover SeqOne's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SeqOne include Strand Life Sciences, Benchling and Helix. Here is the list of Top 10 competitors of SeqOne, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, WestBridge Capital & 92 others	74/100
2nd	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Benchmark & 29 others	73/100
3rd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
4th	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	64/100
5th	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	64/100
6th	Tessera Therapeutics 2017, Cambridge (United States), Series C	Provider of new genome engineering technology for treating multiple diseases	$610M	T. Rowe Price, ADIA & 22 others	63/100
7th	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	SoftBank Vision Fund, True Ventures & 16 others	62/100
8th	Sophia Genetics 2011, Rolle (Switzerland), Public	Provider of artificial intelligence software for analyzing complex medical data	$249M	Generation Investment Management, Endeavour Vision ... & 24 others	62/100
9th	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Two Sigma Ventures & 10 others	62/100
10th	Cellanome 2020, Palo Alto (United States), Series B	Developer of the omic data platform for researchers	$119M	DFJ Growth, Premji Invest & 4 others	59/100
65th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Korys, Elaia & 7 others	44/100